Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 21, 2018
Pharmacy Choice - News - Drug Delivery Systems - May 21, 2018

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 95     Next >>     Go To Page:

5/21/18 - Findings from University of KwaZulu-Natal Provide New Insights into Drug Delivery Systems (Novel DNA Aptamers Against CCL21 Protein: Characterization...
By a News Reporter-Staff News Editor at AIDS Weekly Researchers detail new data in Drugs and Therapies- Drug Delivery Systems. According to news reporting from Durban, South Africa, by NewsRx journalists, research stated, "The chemokine ligand 21 is a cytokine that attracts CCR7-positive cells to the T cell zone of lymph nodes by directional migr
5/21/18 - Lipocine Receives Complete Response Letter for TLANDO From U.S. Food and Drug Administration
By a News Reporter-Staff News Editor at Pharma Business Week Lipocine Inc., a specialty pharmaceutical company, announced that it has received a Complete Response Letter from the United States Food and Drug Administration regarding its New Drug Application for TLANDO?, the Company's oral testosterone product candidate for testosterone replaceme
5/21/18 - Medicure Announces Commencement of Enrollment in SAVI-PCI Trial of AGGRASTAT
By a News Reporter-Staff News Editor at Clinical Trials Week Medicure Inc. is pleased to announce the commencement of enrollment in SAVI-PCI a prospective, multicenter, randomized clinical trial of its commercial product, AGGRASTAT , in the United States. The first sites initiated in the SAVI-PCI study are the Centennial Heart and Vascular Cent
5/21/18 - New Diabetes Mellitus Management Study Findings Have Been Reported by Investigators at Copenhagen University Hospital (Parenteral nutrition and...
New Diabetes Mellitus Management Study Findings Have Been Reported by Investigators at Copenhagen University Hospital. According to news reporting originating in Copenhagen, Denmark, by NewsRx journalists, research stated, "Pancreatogenic diabetes develops in patients undergoing total pancreatectomy and complicates post-surgical management.
5/21/18 - Patent Issued for Methods, Compounds, and Compositions for Inhibition of ROS (USPTO 9963452)
By a News Reporter-Staff News Editor at Pharma Business Week A patent by the inventors Grueneberg, Dorre A.; Kalid, Ori; Xian, Jun; Rajur, Sharanappa B.; Kim, Hwa-Ok; Neelagiri, Venugopal Rao; Salgaonkar, Paresh; Sethumadhavan, Divakaramenon; Moon, Chaeho; Neelagiri, Madhavi, filed on March 13, 2014, was published online on May 8, 2018, according
5/21/18 - Patent Issued for Microarray for Delivery of Therapeutic Agent, Methods of Use, and Methods of Making (USPTO 9962534)
By a News Reporter-Staff News Editor at Pharma Business Week A patent by the inventors Chen, Guohua; Ding, Zhongli; Ghartey-Tagoe, Esi; Shastry, Ashutosh; Worsham, Robert Wade; Singh, Parminder, filed on March 14, 2014, was published online on May 8, 2018, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents
5/21/18 - Patent Issued for Safety Device for a Pre-Filled Syringe and Injection Device (USPTO 9962499)
By a News Reporter-Staff News Editor at Pharma Business Week Sanofi has been issued patent number 9962499, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Roberts, Gareth; Ward, Chris; Ekman, Matthew. This patent was filed on April 13, 2016 and was published online on May 8, 2018.
5/21/18 - Studies from National Research Center Further Understanding of Drug Delivery Systems (Nanotechnology as a Promising Strategy for Anticancer Drug...
By a News Reporter-Staff News Editor at Clinical Trials Week New research on Drugs and Therapies- Drug Delivery Systems is the subject of a report. According to news reporting out of Cairo, Egypt, by NewsRx editors, the research stated, "Cancer was and still a very stressful and urgent disease condition representing a leading cause of death in de
5/20/18 - Takeda to Highlight Broad Oncology Portfolio and Pipeline Data at the American Society of Clinical Oncology (ASCO) and the Congress of the European Hematology Association (EHA) Annual Meetings
Takeda Pharmaceutical Company Limited today announced that the company will feature a total of 14 Takeda Oncology-sponsored presentations at two upcoming medical meetings: the 54th Annual Meeting of the American Society of Clinical Oncology, June 1-5 in Chicago and the 23rd Congress of the European Hematology Association, June 14-17 in Stockholm.
5/19/18 - Adheriums Technology Used for Large Scale Electronic Data Capture in Landmark Mild-Asthma Trials [Kuwait News Agency]
-Adherium, a digital health company that improves medication adherence and patient outcomes, announced the extensive use of its Hailie technology in two landmark clinical trials investigating the treatment of mild asthma, which have just been published in the New England Journal of Medicine and will be presented this weekend at the American Thoraci
5/19/18 - Implantable Drug Delivery Devices Market Stood at US $11.6 Bn in 2011 and Is Predicted to Reach US $21.1 Bn by 2018
Albany, NY 05/18/2018 A new Transparency Market Research report states that the global implantable drug delivery devices market stood at US $11.6 bn in 2011 and is predicted to reach US $21.1 bn by 2018. It is predicted to expand at a CAGR of 8.80% from 2012 to 2018. The title of the report is "Implantable Drug Delivery Devices Market- Global
5/19/18 - Parenteral Drug Delivery: Optimizing and Developing Novel Methods in PFS Industry- Updates at SMi Event
Pre-Filled Syringes West Coast: SMi Groups latest installment in the industry renowned Pre-Filled Syringes global event series welcoming industry leaders this June in San Diego, USA.
5/19/18 - Pfizers Lyrica meets primary endpoint in phase 3 pediatric epilepsy trial [Tehran Times (Iran)]
Pfizer has reported positive top-line results from a phase 3 study, which assessed the use of Lyrica oral solution CV as adjunctive therapy for partial onset seizures in pediatric epilepsy patients one month to less than four years of age. The study was a post-marketing requirement by the U.S. Food and Drug Administration. Pfizer internal medicine
5/18/18 - Adherium's Technology Used for Large ScaleElectronic Data Capture in Landmark Mild-Asthma Trials
Adherium, a digital health company that improves medication adherence and patient outcomes, announced the extensive use of it s Hailie? technology in two landmark clinical trials investigating the treatment of mild asthma, which have just been published in the New England Journal of Medicine and will be presented this weekend at the American
5/18/18 - AGILE THERAPEUTICS INC FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits
The Company had the Type A Meeting to discuss the complete response letter dated December 21, 2017 that the FDA issued in connection with the June 26, 2017 New Drug Application resubmission for the Company's investigational low dose, non-daily combination hormonal contraceptive patch, Twirla. The Company received the final meeting minutes from the
5/18/18 - Agile Therapeutics, Inc. Provides Regulatory Update on Twirla (AG200-15) for the Prevention of Pregnancy
Agile Therapeutics, Inc.,, a women s healthcare company, today announced the content of the official minutes from its Type A meeting with the U.S. Food and Drug Administration held on April 16, 2018 to discuss the complete response letter issued by the FDA on December 21, 2017 relating to the New Drug Application for Twirla, the Company s i
5/18/18 - Amneal Launches Generic for Sabril: Vigabatrin for Oral Solution, USP
By a News Reporter-Staff News Editor at Drug Week Amneal Pharmaceuticals has launched vigabatrin for oral solution USP, a generic equivalent for Sabril . Amneal has also filed an ANDA with US FDA for the tablet form of vigabatrin. Annual U.S. sales of vigabatrin for oral solution were $318 million, according to March 2018 IQVIA? market data.
5/18/18 - Avadel to Present Late-Breaker Data and Product Theater Forum at the 2018 American Urological Association Annual Meeting
Avadel Pharmaceuticals plc, Avadel or the Company, will release research findings from the Phase III clinical trials of AV002 at the American Urological Association Annual Meeting in San Francisco on May 20, 2018 that demonstrate elderly nocturia patients treated with AV002 NOCTIVA? Nasal Spray, an emulsified microdose of desmopr
5/18/18 - Connected Drug Delivery Devices Market Will Hit At A CAGR Of 25.6% From 2015 To 2027 [FARS News Agency]
-The market for connected drug delivery devices is foreseen to witness a stellar growth rate of 25.6% from 2015 to 2027 rising to a valuation of US$ 1,304.7 Mn from US$ 132.2 Mn in 2017. According to the analyst of Future Market Insights, the leading manufacturers of connected drug delivery devices are focusing collaboration with the software compa
5/18/18 - Drug Delivery Systems Market Is Projected to Soar at a Value CAGR of 6.9% from 2017 to 2025: Transparency Market Research Report Added "Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025"
Albany, NY 05/18/2018 Transparency Market Research has published a new report titled "Drug Delivery System Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 2025". Key players introduce new drugs delivery systems and devices in developed markets such a North America and Western Europe. Rise in R&D investme
5/18/18 - Gene Delivery System Market to Expand at a CAGR of over 7.8% from 2017 to 2025: Global Gene Delivery System Market to Surpass US$ 4,281.0 Mn by 2025; Rising Incidence of Chronic Diseases and Technological Advancement to Fuel the Market: Transparency
Albany, NY 05/18/2018 Transparency Market Research has published a new report titled "Gene Delivery System Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 2025". Key players introduce advanced technologies for drug delivery systems in North America and Europe; therefore, these regions are likely to accou
5/18/18 - Global Intravenous Immunoglobulin (IVIG) Market Analysis and Forecast Predictions: Global Intravenous Immunoglobulin (IVIG) Market Analysis and Forecast Predictions
Albany, NY 05/18/2018 Market Research Report Search Engine recently announced the addition of a new research study to its comprehensive collection of research reports. Since the first formulation of intravenous immunoglobulin that gained FDA approval back in 1980 s, the concept has been harnessed relentlessly in the last three decades and adv
5/18/18 - Insmed Appoints Leo Lee to its Board of Directors [National News Agency (Lebanon)]
-Insmed Incorporated, a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced the appointment of Leo Lee to its Board of Directors. Mr. Lee has more than 21 years of experience in the pharmaceutical industry in Japan; most recently at Merck KGaA, a global pharmaceutical company, where he served
5/18/18 - Investigators at University of Toronto Zero in on Drug Delivery Systems (Importance of integrating nanotechnology with pharmacology and physiology...
Investigators at University of Toronto Zero in on Drug Delivery Systems. By a News Reporter-Staff News Editor at Drug Week Current study results on Drugs and Therapies- Drug Delivery Systems have been published. The news reporters obtained a quote from the research from the University of Toronto, "However, in the design and evaluation of these...
5/18/18 - LYRICA (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint
Pfizer, a pharmaceutical company, issued the following news release:. Pfizer Inc. announced today positive top-line results of a Phase 3 study examining the use of LYRICA (R) Oral Solution CV as adjunctive therapy for partial onset seizures in pediatric epilepsy patients one month to less than four years of age. "The Phase 3 top-line results reinf
Articles(s): 1 - 25 of 95     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415